Evidence map›Paper›PMID 26404901›Full record

ArticleScientific reports2015

Microfluidic cytometric analysis of cancer cell transportability and invasiveness.

Zongbin Liu, Yeonju Lee, Joon hee Jang, Ying Li, Xin Han, Kenji Yokoi, Mauro Ferrari, Ledu Zhou, Lidong Qin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Cancer Stem Cell Plasticity - A Deadly Deal.Frontiers in molecular biosciences · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zongbin LiuDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Yeonju LeeDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Joon hee JangDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Ying LiDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Xin HanDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Kenji YokoiDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Mauro FerrariDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Ledu ZhouDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Lidong QinDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Houston Methodist · USCornell University · USThe University of Texas MD Anderson Cancer Center · US

Funding

TRANS-NETWORK PROJECTSU54CA143837 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI PEPPAS, NICHOLAS A · 2009 to 2014
$10.8M
(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-ChipR01CA180083 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI QIN, LIDONG, WU, XIFENG · 2013 to 2016
$2.1M
NCI NIH HHS CA180083NCI NIH HHS R01 CA180083NCI NIH HHS U54 CA143837NCI NIH HHS U54CA143837
6 · The paper itself

Abstract

The extensive phenotypic and functional heterogeneity of cancer cells plays an important role in tumor progression and therapeutic resistance. Characterizing this heterogeneity and identifying invasive phenotype may provide possibility to improve chemotherapy treatment. By mimicking cancer cell perfusion through circulatory system in metastasis, we develop a unique microfluidic cytometry (MC) platform to separate cancer cells at high throughput, and further derive a physical parameter 'transportability' to characterize the ability to pass through micro-constrictions. The transportability is determined by cell stiffness and cell-surface frictional property, and can be used to probe tumor heterogeneity, discriminate more invasive phenotypes and correlate with biomarker expressions in breast cancer cells. Decreased cell stiffness and cell-surface frictional force leads to an increase in transportability and may be a feature of invasive cancer cells by promoting cell perfusion through narrow spaces in circulatory system. The MC-Chip provides a promising microfluidic platform for studying cell mechanics and transportability could be used as a novel marker for probing tumor heterogeneity and determining invasive phenotypes.

Indexed as

Microfluidic Analytical TechniquesMicrofluidicsAnimalsBiomarkersCell Line, TumorCell MovementFlow CytometryGene ExpressionHumansMiceModels, BiologicalNeoplasm InvasivenessNeoplasmsNeoplastic Stem CellsPhenotypeBiomarkers

Identifiers

PMID26404901
PMCPMC4585905
OpenAlexW2408490728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.